Cargando…
Mucins as a New Frontier in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary disease with a median survival of 3–5 years after diagnosis. Recent evidence identifies mucins as key effectors in cell growth and tissue remodeling processes compatible with the processes observed in IPF. Mucin...
Autores principales: | Ballester, Beatriz, Milara, Javier, Cortijo, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780288/ https://www.ncbi.nlm.nih.gov/pubmed/31514468 http://dx.doi.org/10.3390/jcm8091447 |
Ejemplares similares
-
The role of mucin 1 in respiratory diseases
por: Ballester, Beatriz, et al.
Publicado: (2021) -
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
por: Ballester, Beatriz, et al.
Publicado: (2019) -
MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway
por: Ballester, Beatriz, et al.
Publicado: (2021) -
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
por: Ballester, Beatriz, et al.
Publicado: (2020) -
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2018)